切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2021, Vol. 10 ›› Issue (04) : 351 -356. doi: 10.3877/cma.j.issn.2095-3224.2021.04.003

青年专家论坛

英国生物样本库(UK Biobank)在结直肠癌临床研究中的应用
余其澳1, 宋欢2, 汪晓东3,(), 李立3   
  1. 1. 610041 成都,四川大学华西医院胃肠外科;610041 成都,四川大学华西临床医学院
    2. 610041 成都,四川大学华西生物医学大数据中心
    3. 610041 成都,四川大学华西医院胃肠外科
  • 收稿日期:2021-04-25 出版日期:2021-08-30
  • 通信作者: 汪晓东
  • 基金资助:
    四川大学华西医院临床研究孵化项目(2021HXFH052)

Application of UK Biobank in clinical research of colorectal neoplasm

Qi'ao Yu1, Huan Song2, Xiaodong Wang3,(), Li Li3   

  1. 1. Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu 610041, China; West China School of Medicine/West China Hospital of Sichuan University, Chengdu 610041, China
    2. West China Biomedical Data Center, Sichuan University, Chengdu 610041, China
    3. Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
  • Received:2021-04-25 Published:2021-08-30
  • Corresponding author: Xiaodong Wang
引用本文:

余其澳, 宋欢, 汪晓东, 李立. 英国生物样本库(UK Biobank)在结直肠癌临床研究中的应用[J/OL]. 中华结直肠疾病电子杂志, 2021, 10(04): 351-356.

Qi'ao Yu, Huan Song, Xiaodong Wang, Li Li. Application of UK Biobank in clinical research of colorectal neoplasm[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2021, 10(04): 351-356.

生物样本库是一种规范化收集、保存和处置生物样本,为疾病诊断、药物研发等生物医学研究提供研究资源的生物样本管理系统。生物样本库在结直肠癌的临床研究中的应用方向主要为病因分析和风险预测模型建立。其优势主要在于有大量的数据、全面的样本以及能更好地共享数据资源。

The Biobank is a biological sample management system for standardized collection, storage, and disposal of biological samples to provide research resources for disease diagnosis, drug development, and other biomedical researches. The application of Biobank in clinical research of colorectal cancer mainly focuses on cause analysis and the establishment of the risk prediction model. Its advantages mainly lie in having a large number of comprehensive samples of data and preferable sharing of data resources.

1
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
2
UK Biobank [EB/OL].(2021-02-01)[2021-05-20].

URL    
3
王晓民, 郜恒骏. 临床生物样本库的探索与实践[M]. 上海: 上海交通大学出版社, 2017.
4
林敏, 姜岩, 张亚南, 等. 生物样本库及样本应用现状[J]. 现代肿瘤医学, 2016, 24(9): 1490-1493.
5
Macrury S, Finlayson J, Hussey-wilson S, et al. Development of a pseudo/anonymised primary care research database: Proof-of-concept study[J]. Health Informatics J, 2016, 22(2): 113-119.
6
Siu LL, Lawler M, Haussler D, et al. Facilitating a culture of responsible and effective sharing of cancer genome data[J]. Nat Med, 2016, 22(5): 464-471.
7
Pang Y, Kartsonaki C, Guo Y, et al. Socioeconomic status in relation to risks of major gastrointestinal cancers in chinese adults: a prospective study of 0.5 million people[J]. Cancer Epidemiol Biomarkers Prev, 2020, 29(4): 823-831.
8
Tan X, Tang H, Gong L, et al. Integrating genome-wide association studies and gene expression profiles with chemical-genes interaction networks to identify chemicals associated with colorectal cancer[J]. Front Genet, 2020, 11: 385.
9
Ellis L, Canchola AJ, Spiegel D, et al. Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics[J]. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 2018, 36(1): 25-33.
10
Warren Andersen S, Blot WJ, Lipworth L, et al. Association of race and socioeconomic status with colorectal cancer screening, colorectal cancer risk, and mortality in southern US adults [J]. JAMA Netw Open, 2019, 2(12): e1917995.
11
Lin BM, Nadkarni GN, Tao R, et al. Genetics of chronic kidney disease stages across ancestries: The PAGE study [J]. Front Genet, 2019, 10: 494.
12
Ong JS, Gharahkhani P, An J, et al. Vitamin D and overall cancer risk and cancer mortality: a Mendelian randomization study[J]. Hum Mol Genet, 2018, 27(24): 4315-4322.
13
Cho S, Song N, Choi JY, et al. Effect of citric acid cycle genetic variants and their interactions with obesity, physical activity and energy intake on the risk of colorectal cancer: results from a nested case-control study in the UK Biobank[J]. Cancers(Basel), 2020, 12(10): 2939.
14
Peila R, Arthur RS, Rohan TE. Sex hormones, SHBG and risk of colon and rectal cancer among men and women in the UK Biobank[J]. Cancer Epidemiol, 2020, 69: 101831.
15
Larsson SC, Carter P, Vithayathil M, et al. Insulin‐like growth factor‐1 and site‐specific cancers: A Mendelian randomization study[J]. Cancer Medicine, 2020, 9(18): 6836-6842.
16
Knuppel A, Fensom GK, Watts EL, et al. Circulating insulin-like growth factor-I concentrations and risk of 30 cancers: prospective analyses in UK Biobank[J]. Cancer Res, 2020, 80(18): 4014-4021.
17
Murphy N, Carreras-torres R, Song M, et al. Circulating levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 associate with risk of colorectal cancer based on serologic and mendelian randomization analyses[J]. Gastroenterology, 2020, 158(5): 1300-1312.e20.
18
He MM, Fang Z, Hang D, et al. Circulating liver function markers and colorectal cancer risk: A prospective cohort study in the UK Biobank[J]. Int J Cancer, 2020, 148(8): 1867-1878.
19
Hillreiner A, Baumeister SE, Sedlmeier AM, et al. Association between cardiorespiratory fitness and colorectal cancer in the UK Biobank[J]. Eur J Epidemiol, 2020, 35(10): 961-973.
20
Bradbury KE, Murphy N, Key TJ. Diet and colorectal cancer in UK Biobank: a prospective study[J]. Int J Epidemiol, 2020, 49(1): 246-258.
21
Knuppel A, Papier K, Fensom GK, et al. Meat intake and cancer risk: prospective analyses in UK Biobank[J]. Int J Epidemiol, 2020, 49(5): 1540-1552.
22
Bernstein AM, Song M, Zhang X, et al. Processed and unprocessed red meat and risk of colorectal cancer: analysis by tumor location and modification by time[J]. PLoS One, 2015, 10(8): e0135959.
23
Tabung FK, Liu L, Wang W, et al. Association of dietary inflammatory potential with colorectal cancer risk in men and women[J]. JAMA Oncology, 2018, 4(3): 366-373.
24
Noor AM, Holmberg L, Gillett C, et al. Big Data: the challenge for small research groups in the era of cancer genomics[J]. Br J Cancer, 2015, 113(10): 1405-1412.
25
谷鸿秋, 周支瑞, 章仲恒, 等. 临床预测模型: 基本概念、应用场景及研究思路[J]. 中国循证心血管医学杂志, 2018, 10(12): 1454-1456+1462.
26
Jia GC, Lu YC, Wen WQ, et al. Evaluating the utility of polygenic risk scores in identifying high-risk individuals for eight common cancers[J]. JNCI Cancer Spectr, 2020, 4(3): pkaa021.
27
Li X, Timofeeva M, Spiliopoulou A, et al. Prediction of colorectal cancer risk based on profiling with common genetic variants[J]. Int J Cancer, 2020, 147(12): 3431-3437.
28
Saunders CL, Kilian B, Thompson DJ, et al. External validation of risk prediction models incorporating common genetic variants for incident colorectal cancer using uk biobank[J]. Cancer Prev Res(Phila), 2020, 13(6): 509-520.
29
Kodeda K, Asting AG, Lonnroth C, et al. Genomic CGH-assessed structural DNA alterations in rectal carcinoma as related to local recurrence following primary operation for cure[J]. Int J Oncol, 2012, 41(4): 1397-1404.
30
Messick CA, Sanchez J, Dejulius KL, et al. CEACAM-7: a predictive marker for rectal cancer recurrence[J]. Surgery, 2010, 147(5): 713-719.
31
Messick CA, Church JM, Liu X, et al. Stage Ⅲ colorectal cancer: molecular disparity between primary cancers and lymph node metastases [J]. Ann Surg Oncol, 2010, 17(2): 425-431.
[1] 罗青杉, 梅海涛, 郝家领, 蔡锦锋, 周润楷, 温玉刚. 连接蛋白43通过调控细胞周期抑制结直肠癌的增殖机制研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 344-349.
[2] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[3] 阮星星, 黄智渊, 刘芙香, 狄金明. 从临床医师诊治患者的思路出发撰写临床研究论文[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 397-401.
[4] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[5] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[6] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[7] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[8] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[9] 张蔚林, 王哲学, 白峻阁, 黄忠诚, 肖志刚. 利用TCGA数据库构建基于miRNA的结直肠癌列线图预后模型[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 381-388.
[10] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[11] 任佳琪, 刁德昌, 何自衍, 张雪阳, 唐新, 李文娟, 李洪明, 卢新泉, 易小江. 网膜融合线导向的脾曲游离技术在左半结肠癌根治术中的应用[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 362-367.
[12] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[13] 季鹏程, 鄂一民, 陆晨, 喻春钊. 循环外泌体相关生物标志物在结直肠癌诊断中的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 265-273.
[14] 李佳莹, 王旭丹, 梁雪, 张雷, 李佳英. 1990~2021年中国结直肠癌死亡趋势分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 274-279.
[15] 戈伟, 陈刚. 纳米炭导航行淋巴示踪在结直肠癌TNM分期中淋巴分期价值的临床研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(04): 288-293.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?